A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Public ClinicalTrials.gov record NCT00002318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the efficacy of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the treatment of severe AIDS-related Kaposi's sarcoma (KS) by comparison with the established therapy ABV: Adriamycin (doxorubicin)/bleomycin/vincristine. To evaluate the safety and tolerance of DOX-SL compared to ABV in a population of AIDS patients with severe KS.
Study identification
- NCT ID
- NCT00002318
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Interventions
- Doxorubicin hydrochloride (liposomal) Drug
- Bleomycin sulfate Drug
- Vincristine sulfate Drug
- Doxorubicin hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 28
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Ctr | Berkeley | California | 94705 | — |
| Pacific Oaks Med Group | Beverly Hills | California | 90211 | — |
| Hematology - Oncology Med Group of San Fernando Valley | Encino | California | 91436 | — |
| Dr Becky Miller | Los Angeles | California | 90048 | — |
| Apogee Med Group | San Diego | California | 92103 | — |
| UCSF - San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Kaiser Permanente Med Ctr | San Francisco | California | 94115 | — |
| UCSF | San Francisco | California | 94117 | — |
| San Francisco Veterans Administration Med Ctr | San Francisco | California | 94121 | — |
| UCSF | San Francisco | California | 941430324 | — |
| Pacific Oaks Med Group | Sherman Oaks | California | 91403 | — |
| Dr Mahmoud Mustafa | Washington D.C. | District of Columbia | 20037 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| H Lee Moffit Cancer Ctr and Research Institute | Tampa | Florida | 33612 | — |
| American Med Research Institute | Atlanta | Georgia | 30329 | — |
| Infectious Disease Rsch Consortium of GA / SE Clin Resources | Atlanta | Georgia | 30345 | — |
| Northwestern Med Faculty Foundation | Chicago | Illinois | 60611 | — |
| Rush Presbyterian Med College | Chicago | Illinois | 60612 | — |
| Illinois Masonic Med Ctr / The Cancer Ctr | Chicago | Illinois | 60657 | — |
| Henry Ford Hosp | Detroit | Michigan | 48202 | — |
| Washington Univ | St Louis | Missouri | 63108 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Saint Vincent's Hosp and Med Ctr | New York | New York | 10011 | — |
| New York Univ Med Ctr | New York | New York | 10016 | — |
| Saint Luke's - Roosevelt Hosp Ctr | New York | New York | 10023 | — |
| Graduate Hosp / Tuttleman Cancer Ctr | Philadelphia | Pennsylvania | 19146 | — |
| Comprehensive Care Ctr | Dallas | Texas | 75235 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002318 live on ClinicalTrials.gov.